Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003084102 | SCV003469425 | likely benign | Jeune thoracic dystrophy; Nephronophthisis | 2025-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004071808 | SCV004972681 | uncertain significance | Inborn genetic diseases | 2023-12-28 | criteria provided, single submitter | clinical testing | The c.2251C>G (p.Q751E) alteration is located in exon 17 (coding exon 17) of the TTC21B gene. This alteration results from a C to G substitution at nucleotide position 2251, causing the glutamine (Q) at amino acid position 751 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |